Table 2. OR for proceeding with surgery for patients treated with chemoradiation with concurrent CAPE or GEM.
Concurrent Chemo | Borderline resectable and resectable | Borderline resectable only | |||
---|---|---|---|---|---|
OR (95% CI) | AOR (95% CI) | OR (95% CI) | AOR (95% CI) | ||
GEM | Ref. | Ref. | Ref. | Ref. | |
CAPE | 9.33 (1.50–58.20) | 24.75 (1.21–505.13) | 7.00 (1.10–44.61) | 25.34 (1.14–563.72) |
AOR is adjusted by year of diagnosis, weeks of neoadjuvant chemotherapy, and type of neoadjuvant chemotherapy. OR, odd ratios; CAPE, capecitabine; GEM, gemcitabine; Chemo, chemotherapy; CI, confidence interval; AOR, adjusted odd ratios.